Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.

NIF 502609800
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €16,267,780 67 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €16,267,780 67 contracts
A2 · Late Publication €5,322,914,855 1,435 contracts
Contract published to BASE more than 10 days after the signing date
LOW €5,322,914,855 1,435 contracts
A5 · Threshold Splitting €2,953,810 62 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €2,953,810 62 contracts
A6 · Low Competition €2,660,248 27 contracts
Only one bidder participated in a competitive procedure
MEDIUM €2,660,248 27 contracts
A9 · Abnormal Price Reduction €6,550,001,606 614 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €6,550,001,606 614 contracts
C3 · Missing Mandatory Fields €3,398,167 50 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €3,398,167 50 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

210
€519,225,237
55
€326,327,827
97
€293,023,862
31
€284,443,340
19
€270,557,693
77
€266,963,845
25
€260,016,401
86
€253,474,890
140
€250,219,002
94
€247,412,555
24
€242,087,789
19
€221,963,916
9
€218,182,967
35
€217,334,268
214
€214,411,343
64
€210,591,444
10
€206,821,443
19
€202,938,635
15
€196,820,942
17
€183,522,067
Page 1 of 3 · 52 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 27 contracts

AL B) EXCL SPMS (2024_0961) VARIOS
PT · 12397818 · Ao abrigo de acordo-qu...
A6 · Low Competition
€245,224 2026-01-02
HORMONA LIBERTADORAA GONADOTROPINA - TRIPTORRELINA
PT · 11309383 · Ajuste Direto Regime G...
A6 · Low Competition
€12,195 2025-03-26
EAD20250061 - AQUISIÇÃO DE RELAXANTES MUSCULARES ACÇÃO CENTRAL - TOXINA BOTULÍNICA
PT · 11279434 · Ajuste Direto Regime G...
A6 · Low Competition
€114,409 2025-03-12
HORMONA LIBERTADORA GONADOTROPINA-TRIPTORRELINA
PT · 11270342 · Ao abrigo de acordo-qu...
A6 · Low Competition
€95,164 2025-03-10
CABOZANTINIB 60 MG COMP
PT · 11289093 · Ajuste Direto Regime G...
A6 · Low Competition
€41,999 2025-03-07
BEAD20250191 - AQUISIÇÃO DE HIPOTÁLAMO E HIPÓFISE - LANREOTIDA
PT · 11252314 · Ao abrigo de acordo-qu...
A6 · Low Competition
€308,815 2025-02-27
Aquisição de LANREOTIDA 120 MG488 MG SOL INJ SER 0.5 ML SC
PT · 11250631 · Ao abrigo de acordo-qu...
A6 · Low Competition
€136,242 2025-02-20
Fornecimento de Triptorrelina e Ianreotida ao HSEIT, EPER.
PT · 11226700 · Ajuste Direto Regime G...
A6 · Low Competition
€43,154 2025-02-13
AQUISIÇÃO DE LANREOTIDA 120 MG/488 MG SOL INJ SER 0.5 ML SC
PT · 11099798 · Ajuste Direto Regime G...
A6 · Low Competition
€68,121 2024-12-20
HORMONA LIBERTADORA GONADOTROPINA - TRIPTORRELINA
PT · 11088455 · Ao abrigo de acordo-qu...
A6 · Low Competition
€24,593 2024-12-16
1BCP20240272 - LANREOTIDA
PT · 11046761 · Consulta Prévia
A6 · Low Competition
€54,496 2024-11-25
1BCP20240272 - LANREOTIDA
PT · 10968155 · Consulta Prévia
A6 · Low Competition
€54,496 2024-10-14
AQUISIÇÃO DE LANREOTIDA 120 MG/488 MG SOL INJ SER 0.5 ML SC
PT · 10969908 · Ajuste Direto Regime G...
A6 · Low Competition
€90,828 2024-10-14
LANREOTIDA 120 MG/488 MG SOL INJ SER 0.5 ML SC
PT · 11029988 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€36,331 2024-08-22
RELAXANTES MUSCULARES AÇÃO CENTRAL - TOXINA BOTULÍNICA
PT · 10875539 · Ao abrigo de acordo-qu...
A6 · Low Competition
€17,694 2024-08-19
AQUISIÇÃO DE LANREOTIDA 120 MG/488 MG SOL INJ SER 0.5 ML SC
PT · 10877271 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€45,414 2024-08-06
BEAD20240363 - AQUISIÇÃO DE INIBIDORES DE TIROSINACINASES - CABOZANTINIB - 3 MESES
PT · 10832031 · Ao abrigo de acordo-qu...
A6 · Low Competition
€21,000 2024-07-22
INIBIDORES DE TIROSINACINASES - CABOZANTINIB
PT · 10806557 · Ao abrigo de acordo-qu...
A6 · Low Competition
€24,500 2024-07-05
INIBIDORES DE TIROSINACINASES
PT · 10795326 · Ao abrigo de acordo-qu...
A6 · Low Competition
€42,120 2024-06-27
INIBIDORES DE TIROSINACINASES - CABOZANTINIB - 1º SEMESTRE
PT · 10745947 · Ao abrigo de acordo-qu...
A6 · Low Competition
€70,200 2024-05-31
Fornecimento de Triptorrelina ao Hospital de Santo Espírito da Ilha Terceira, EPER
PT · 10673296 · Ajuste Direto Regime G...
A6 · Low Competition
€24,500 2024-04-17
Medicamentos-Citotóxicos
PT · 10665447 · Ao abrigo de acordo-qu...
A2 · Late Publication A6 · Low Competition
€568,166 2024-03-20
2024001148 – Aquisição de medicamentos
PT · 10665521 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€12,296 2024-03-19
EX/1022/2024 - Medicamento A.U.E
PT · 10891408 · Contratação excluída II
A2 · Late Publication A6 · Low Competition
€158,599 2024-03-02
Aquisição de Medicamentos diversos ao abrigo do CPA 2021/55, para a ULSASI, para o ano 2024
PT · 10939356 · Ao abrigo de acordo-qu...
A2 · Late Publication A6 · Low Competition
€272,999 2024-02-27
AQUISIÇÃO DE DCI MEDICAMENTOS - IPSEN PORTUGAL
PT · 10654177 · Ajuste Direto Regime G...
A2 · Late Publication A6 · Low Competition
€76,693 2024-01-30
31/206/2024 - Medicamentos Triptorrelina + Cabozantinib
PT · 10629073 · Ao abrigo de acordo-qu...
A2 · Late Publication A6 · Low Competition
€0 2024-01-25
Overview
Total Value Won
€6,626,637,573
Contracts Won
1,973
Score 70600 · CRITICAL RISK
NIF
502609800
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.A. [P-f417]
    Vogal
    since 2023-01-04
  • A.C. [P-19a3]
    Presidente
    since 2019-11-05
  • A.C. [P-19a3]
    Presidente
    since 2023-01-04
  • C.F. [P-aacf]
    Vogal
    since 2015-03-05
  • E.H. [P-639f]
    Vogal
    since 2014-04-02
  • E.H. [P-639f]
    Vogal
    since 2015-03-05
  • G.G. [P-d47a]
    Presidente
    since 2026-03-26
  • G.W. [P-488a]
    Presidente
    since 2014-12-04
  • J.P. [P-30d5]
    Vogal
    since 2016-05-16
  • L.P. [P-e470]
    Vogal
    since 2020-12-19
  • L.P. [P-e470]
    Vogal
    since 2023-01-04
  • L.G. [P-9eca]
    Vogal
    since 2016-05-16
  • M.C. [P-186f]
    Vogal
    since 2025-05-19
  • P.M. [P-62b5]
    Vogal
    since 2009-05-06
  • R.G. [P-95e5]
    Vogal
    since 2026-03-26
  • C.J. [P-e2b7]
    Fiscal Único
    since 2023-01-04
  • C.J. [P-e2b7]
    Fiscal Único
    since 2025-05-19
  • C.L. [P-db3e]
    Fiscal Único
    since 2018-06-21
  • D.A. [P-c2b1]
    Fiscal Único
    since 2018-06-21
  • J.E. [P-a0dd]
    Fiscal Único
    since 2016-12-14
  • J.G. [P-0a73]
    Fiscal Único
    since 2009-05-06
  • J.G. [P-0a73]
    Fiscal Único
    since 2015-03-05
  • K.A. [P-e283]
    Fiscal Único
    since 2009-05-06
  • K.A. [P-e283]
    Fiscal Único
    since 2015-03-05
  • P.A. [P-4562]
    Fiscal Único
    since 2023-01-04
  • P.A. [P-4562]
    Fiscal Único
    since 2025-05-19
  • A.A. [P-f417]
    Vogal
    2025-05-19 → 2026-03-26
  • A.E. [P-f7c9]
    Vogal
    2019-05-28 → 2022-10-03
  • A.C. [P-19a3]
    Presidente
    2025-05-19 → 2026-03-26
  • A.M. [P-e4bd]
    Presidente
    2009-05-06 → 2014-12-04
  • C.F. [P-aacf]
    Vogal
    2012-11-22 → 2016-04-08
  • F.G. [P-310d]
    Vogal
    2009-05-06 → 2012-11-16
  • G.W. [P-488a]
    Vogal
    2012-11-22 → 2014-04-02
  • G.W. [P-488a]
    Presidente
    2015-03-05 → 2015-09-28
  • J.P. [P-30d5]
    Vogal
    2018-06-21 → 2019-03-27
  • L.G. [P-9eca]
    Presidente
    2018-06-21 → 2019-11-05
  • M.C. [P-d530]
    Vogal
    2019-11-05 → 2020-12-09
  • P.M. [P-62b5]
    Vogal
    until 2012-11-16
  • S.D. [P-b05c]
    Vogal
    2018-06-21 → 2019-11-05
  • J.G. [P-0a73]
    Fiscal Único
    until 2016-12-14
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned